Aids Testing And Treatment Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

1
Aids Testing And Treatment Market
sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Aids Testing And Treatment Market Global
Scenario, Market Size, Outlook, Trend, and
Forecast, 2019 2028

• The Acquired immunodeficiency syndrome (AIDS)
  testing and treatment market is expected to grow
  at a CAGR of 4.7 from 2021 to 2028. Acquired
  immunodeficiency syndrome (AIDS) is the most
  catastrophic, widespread and incurable disease
  prevalent across the world. In a report published
  in 2013 by the World Health Organization (WHO),
  total death accounted at rank six when compared
  on the parameter of total deaths by a disease
  and and approximated 35 million people across the
  globe are affected by it. It is a condition where
  immune system fails, leading to opportunistic
  infections that occurs via transfer of blood,
  vaginal fluid, semen, pre-ejaculate, or breast
  milk and major routes of infection transmission
  are consists of unsafe sex, contaminated needles,
  perinatal transmission, breast milk and infected
  blood products. The disease is mostly prevalent
  in the developing and underdeveloped countries on
  a major scale due to the lack of adequate
  treatment facilities and preventive measures.
  However, permanent cure for acquired
  immunodeficiency syndrome is still not available
  in the medical healthcare market.
• Treatments of AIDS gives opportunities to
  patients to live a normal life by reducing the
  intensity of disease, increasing the survival
  time and patients are rapidly treated due to
  technological upgradation and improvement
  enabling early interventions to prevent disease
  progression to an advanced stage which allows
  early interventions to prevent disease
  progression to further advanced stages of AIDS.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
MARKET DRIVERS

• Increasing awareness about the availability of
  HIV therapeutics in the market and cost-effective
  drug therapies for HIV are driving the global HIV
  therapeutics market. However, unsuccessful
  implementation of treatment in some cases,
  introduction of generic drugs and lack of skilled
  professionalism the market are restraining the
  HIV therapeutics market. The global HIV test and
  treatment market is driven due to increasing
  number of HIV infection cases, technological
  advancement in HIV diagnosis, rise in research
  activities for developing HIV vaccines and lack
  of awareness about the modes of transmission of
  the virus.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
REGIONAL INSIGHTS

• When it comes to regional analysis, North America
  is the leading HIV-1 therapeutics market in 2015
  owing to the high treatment expense, increasing
  prevalence, and the introduction of drugs with
  improved efficiency. Successful players of this
  market include, Complera by Gilead Sciences Inc.
  Moreover, In the year 2016, North America and
  Europe together rare accounting for a high
  prevalence of 2.4 million people suffering from
  this infection. In contemporary times, around 5
  million people in Asia Pacific and around 1.5
  million people in the Latin American region are
  living with this infection.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5
KEY MARKET PLAYERS IN THE AIDS TESTING AND
TREATMENT MARKET

• Leading players in the acquired immunodeficiency
  syndrome testing and treatment market are Shire
  Plc., AstraZeneca Eli Lilly and Company, Merck
  KGaA, Sanofi, Pfizer, Inc., Amgen Inc., Biogen
  Inc., Novartis AG, Actelion Ltd, Daiichi Sankyo
  Company, etc. Alliances and partnerships are
  common as market players are aiming to synergize
  their programs and develop different complicated
  therapies by complementing other.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
SEGMENTATION OF ACQUIRED IMMUNODEFICIENCY
SYNDROME (AIDS) TESTING AND TREATMENT MARKET

• By Class
• Nucleoside Reverse Transcriptase Inhibitors
  (NRTIs)
• Abacavir (ABC)
• Didanosine (ddI)
• Zidovudine or azidothymidine (ZDV or AZT)
• Emtricitabine (FTC)
• Others (Stavudine (d4T), etc.)
• Non-nucleoside Reverse Transcriptase Inhibitors
  (NNRTIs)
• Efavirenz (EFZ)
• Etravirine (ETR)
• Nevirapine (NVP)
• Othets (rilpivirine (RPV), etc.)
• By Application
• Hospital Pharmacy
• Retail Pharmacy
• Others

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
7
KEY MARKET PLAYERS

• Takeda
• AstraZeneca Eli Lilly and Company
• Merck KGaA
• Sanofi
• Pfizer
• Amgen
• Biogen
• Novartis
• Actelion
• Daiichi Sankyo Company

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
8
Contact Us

• Accurize Market Research Pvt. Ltd.
• PATNA OFFICE K-129,
• PC COLONY,
• HANUMAN NAGAR,
• KANKARBAGH, PATNA, PIN-800020
• Emailhelp_at_accurizemarketresearch.com
• CONTACT NO1-339-368-6383

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research